CarMax's stock rallies after earnings, sales rise above expectations

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

United Kingdom News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

Shares of CarMax Inc. |phrase background-info='BRIEFING-BOOK' name='kmx' significance='MWLEGACY' type='COMPANY' vrtysux='COMPANY|kmx'||/phrase| surged 1% in premarket trade Wednesday, after the used car retailer reported a fiscal second-quarter profit and sales that rose above expectations, as improved conversion rates offset lower store traffic. Net earnings for the quarter to Aug. 31 increased to $220.9 million, or $1.24 a share, from $181.4 million, or 98 cents a share, in the same period a year ago. The FactSet consensus was for earnings of $1.22 a share. Sales rose 8.6% to $4.77 billion, above the FactSet consensus of $4.65 billion, as used vehicle sales rose 7.6% to $3.98 billion to top expectations of $3.95 billion. Same-store used unit sales rose 2.1%, beating the FactSet consensus of a 0.6% increase. The stock had edged up 0.7% over the past three months through Tuesday, while the S&P 500 |phrase background-info='BRIEFING-BOOK' name='spx' significance='MWLEGACY' type='COMPANY' vrtysux='COMPANY|spx'||/phrase| has gained 7.1%.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in UK
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cardinal Health's stock surges after earnings, revenue rise above expectationsShares of Cardinal Health Inc. rallied 2.9% in premarket trade Thursday after the healthcare services company reported fiscal first-quarter profit and revenue that rose above expectations, boosted by strength in its pharmaceuticals business. Net income rose to $593 million, or $1.94 a share, from $115 million, or 36 cents a share, in the same period a year ago, with the naviHealth divestiture resulting in a gain of $503 million. Excluding non-recurring items, adjusted earnings per share came to $1.29, above the FactSet consensus of $1.08. Revenue increased 8% to $35.2 billion, beating the FactSet consensus of $33.7 billion. Pharmaceutical segment revenue grew 9% to $31.4 billion, well above the FactSet consensus of $29.8 billion. The company affirmed its 2019 adjusted EPS outlook of $4.90 to $5.15, which surrounds the FactSet consensus of $4.99. The stock has rallied 9.6% over the past three months through Wednesday, while the SPDR Health Care Select Sector ETF has gained 3.4% and the S&P 500 has slipped 1.5%.
Source: MarketWatch - 🏆 3. / 97 Read more »

GE's stock jumps after earnings missed, but revenue rose above expectations
Source: MarketWatch - 🏆 3. / 97 Read more »

UPS's stock surges after earnings rises above expectations
Source: MarketWatch - 🏆 3. / 97 Read more »

Honeywell's stock jumps after earnings beat expectations, sales meetShares of Honeywell International ran up 3.2% in premarket trade Friday, after the diversified industrial company reported third-quarter earnings that beat expectations, as revenue met. Net income rose to $2.34 billion, or $3.11 a share, from $1.35 billion, or $1.74 a share, in the same period a year ago. Excluding non-recurring items, adjusted earnings per share came to $2.03, above the FactSet consensus of $1.99. Sales increased to $10.76 billion from $10.12 billion, matching the FactSet consensus, as better-than-expected aerospace and safety and productivity solutions sales offset home and building technologies and performance materials sales that were slightly below forecasts. The company lowered its 2018 outlook, to reflect the spinoff of Garrett Motion Inc. . Honeywell expects 2018 adjusted EPS of $7.95 to $8.00, down from previous guidance of $8.10 to $8.20, while the sales outlook was lowered to $41.7 billion to $41.8 billion from $43.1 billion to $43.6 billion. Thes tock has gained 2.3% year to date through Thursday, while the Dow Jones Industrial Average has advanced 2.7%.
Source: MarketWatch - 🏆 3. / 97 Read more »

Intel stock rallies on raised outlook, earnings beat for server and PC salesIntel Corp.’s beleaguered shares rallied in the extended session Thursday after the chip giant raised its outlook for the year and soundly beat Wall Street estimates in its largest business segments.
Source: MarketWatch - 🏆 3. / 97 Read more »

Stocks rise in afternoon trading, buoyed by oil rally and strong holiday retail salesStocks rose Wednesday trading, two days after the Standard & Poor’s 500 teetered on the brink of bear territory. Expected Ya, this is all for real... Christmas consumerism saved us all! Truly a miracle
Source: USATODAY - 🏆 100. / 63 Read more »